đź’¨ Abstract
Gilead Sciences Inc. reported lower-than-expected earnings of $1.04 per share for the first quarter of 2025, with adjusted earnings of $1.81 per share. The Foster City, California-based company's revenue also fell short of expectations, totaling $6.67 billion compared to the forecasted $6.84 billion. Despite the miss, Gilead anticipates full-year earnings to be between $7.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Rays rookie outfielder Jake Mangum placed on 10-day injured list with groin strain -
Raiders address NFL’s worst rushing offense by drafting Boise State RB Ashton Jeanty at No. 6 -
Metro’s future: No rail expansion, more bus lanes -
Jets select Missouri offensive tackle Armand Membou with the No. 7 overall pick in NFL draft -
The Browns bring in Journey for a concert before the start of the NFL draft -
San Francisco inches closer to adopting drug policy with abstinence as its primary goal -
Cleveland Browns trade down, take Michigan DT Mason Graham with the 5th pick in the NFL draft -
Patriots select left tackle Will Campbell of LSU with No. 4 pick in NFL draft -
Director de la FundaciĂłn Nacional de Ciencias de EE.UU. renuncia en medio de cambios impulsados por Gobierno de Trump -
Fordham basketball hit with NCAA sanctions for improper benefits to recruits -
Powered by MessengerX.io